Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MER-101 vs Zometa in HRPC
NCT00636740Phase 2Completed
- Sponsor
- Merrion Pharmaceuticals
- Start
- Feb 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of omeprazole in bone metastasis, prostate cancer (PCa), sponsored by Merrion Pharmaceuticals. Started Feb 2008; status: completed.
02
Drugs
omeprazole
03
Conditions
bone metastasisprostate cancer (PCa)
Beyond the preview
Go deeper on NCT00636740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00636740.